TEVA
Teva Pharmaceutical Industries Limited
NYSE · ILHealthcareDrug Manufacturers - Specialty & Generic
$31.00-3.22%
Price as of Jul 20, 2026
TEVA valuation
Teva Pharmaceutical Industries Limited valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 10.97x
- P/E 2026E
- 11.54x
- P/E 2027E
- 10.12x
- P/E 2028E
- 9.07x
- P/S forward
- 2.16x
Trailing multiples
- P/E TTM
- 22.63x
- PEG TTM
- 0.21x
- Price / book
- 4.39x
- Price / sales
- 2.08x
- Price / cash flow
- 21.06x
Enterprise value
- Enterprise value
- $49.3B
- EV / sales
- 2.84x
- EV / EBITDA
- 15.07x
- EV / EBIT
- 21.52x
- Market cap
- $36.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.